Stada will strengthen its Consumer Healthcare business in key markets like Germany and the UK with the acquisition from Sanofi of an OTC brand portfolio including Opticrom eye drops and Omnivit vitamins.
Stada is set to acquire a basket of established OTC brands from Sanofi after identifying untapped growth potential in the portfolio.
The company said the deal will expand significantly its Consumer Healthcare offering with local and regional brands marketed by Sanofi in Belgium, Germany,
The Belgian value-added medicines specialist company struck two commercialization deals over its novel valacyclovir oral suspension that span three continents, marking a further milestone in the product’s development.
A free trade agreement struck between the UK and India could over “significant benefits for the generic and biosimilar sectors,” Medicines UK believes. The off-patent industry association has also suggested further avenues for collaboration between the two governments on regulatory pathways and supply security.
Niche generics company Aspire Pharma has struck a deal to acquire a portfolio of products from fellow UK firm Tetris Pharma as it is wound up, paying Tetris parent Arecor £0.5m for UK distribution rights and inventory.
Apotex has expanded an alliance formed with Formosa in August for its novel clobetasol propionate ophthalmic treatment, adding Mexican rights to its existing deal for the Canadian market.
